UBS Group AG - HTG MOLECULAR DIAGNOSTICS IN ownership

HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 22 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q2 2020$27,000
+575.0%
38,308
+172.4%
0.00%
Q1 2020$4,0000.0%14,061
+134.0%
0.00%
Q4 2019$4,0006,009
+909.9%
0.00%
Q3 2019$0
-100.0%
595
-92.3%
0.00%
Q2 2019$13,000
+30.0%
7,695
+79.8%
0.00%
Q1 2019$10,000
-81.5%
4,280
-79.9%
0.00%
Q4 2018$54,000
+1700.0%
21,260
+3473.1%
0.00%
Q3 2018$3,000
-88.0%
595
-92.1%
0.00%
Q2 2018$25,000
+1150.0%
7,531
+1452.8%
0.00%
Q1 2018$2,000
+100.0%
4850.0%0.00%
Q4 2017$1,000
-83.3%
485
-86.2%
0.00%
Q3 2017$6,000
+100.0%
3,524
+234.0%
0.00%
Q2 2017$3,000
-97.8%
1,055
-94.7%
0.00%
Q1 2017$137,000
+878.6%
19,773
+216.8%
0.00%
Q3 2016$14,000
-80.8%
6,242
-76.7%
0.00%
Q2 2016$73,000
+180.8%
26,749
+350.7%
0.00%
Q4 2015$26,000
+420.0%
5,935
+1261.2%
0.00%
Q2 2015$5,0004360.00%
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q4 2015
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 2,426,300$802,0000.74%
Cowen Prime Services LLC 1,411,500$466,0000.23%
GSA CAPITAL PARTNERS LLP 1,205,873$398,0000.07%
Nantahala Capital Management 5,113,958$1,690,0000.05%
HighMark Wealth Management LLC 80,000$26,0000.02%
Kalos Management, Inc. 72,858$24,0000.01%
Qube Research & Technologies Ltd 585,187$193,0000.00%
WINTON GROUP Ltd 190,146$63,0000.00%
Ironwood Financial, llc 1,571$1,0000.00%
Virtu Financial LLC 12,049$4,0000.00%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders